Planning an Adaptive Clinical Trial of Cognitive Training to Improve Function and Delay Dementia
规划认知训练的适应性临床试验以改善功能并延缓痴呆
基本信息
- 批准号:9791317
- 负责人:
- 金额:$ 97.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-30 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseApplications GrantsAttentionAttenuatedBiological MarkersBloodBlood VesselsBrainCharacteristicsClinical ResearchClinical TrialsClinical trial protocol documentCognitionCognitiveCognitive deficitsDataDementiaDevelopmentDiagnosisEducationElderlyEnrollmentEthnic OriginExerciseGoalsGrantHealthHippocampus (Brain)IncidenceIndividualInternationalInterventionInvestigationLifeLiving StandardsManualsMeasuresMedicalMethodologyMinority RecruitmentMissionMorbidity - disease rateNeuropsychologyOutcomeOutcome MeasureParticipantPerfusionPersonsPhasePopulationPrevalencePreventionPreventiveProbabilityProceduresProtocols documentationPublic HealthRaceRandomizedRandomized Clinical TrialsRecommendationResearchResearch TrainingRestRiskSample SizeSamplingStructureTestingTimeTrainingTraining TechnicsUnited States National Institutes of HealthWhite Matter HyperintensityWorkactive controlarmblood-based biomarkercerebral microbleedsclinical Diagnosiscognitive testingcognitive trainingcommunity planningcostdementia riskdesigndisabilityexpectationfunctional declinehigh riskimprovedimproved functioningindexinginnovationinstrumental activity of daily livingmild cognitive impairmentneuroimagingneuroimaging markerneurotropicnovelpilot trialprocessing speedrecruitsexsimulationsocialsuccesssustained attentionwhite matter
项目摘要
PROJECT SUMMARY
Our analyses from the ACTIVE study showed that one type of targeted cognitive training (CT) reduced risk of
dementia by up to 48% across 10 years. While these results are encouraging, evidence is inconclusive to rec-
ommend CT for dementia prevention. Many efficacious CT techniques now exist, but have distinct cognitive
effects. Given that cognitive deficits are varied among those at risk for dementia, a combination of CT tech-
niques may be most efficacious. Emerging evidence indicates that combining CT techniques can either en-
hance or attenuate cognitive gains. However, no studies have been designed to determine the most efficacious
CT combinations. Furthermore, no studies have been designed to examine the longitudinal effects of CT on
dementia diagnoses. We will engage international experts in CT, mild cognitive impairment (MCI)/dementia,
recruitment and retention, neuropsychological assessment, neuroimaging, biomarkers, and adaptive trial de-
sign to plan and pilot test an adaptive randomized clinical trial (RCT). The RCT will determine the most effica-
cious combinations of CT exercises to attenuate functional decline and delay dementia among older adults at
risk due to MCI. We will first develop an effective recruitment plan of community engagement to include those
often under-represented in clinical research and enroll a sample representative of the US older adult popula-
tion with regard to sex, ethnicity, race, and education. In phase I a pilot trial will be conducted to refine the re-
cruitment and retention plan, establish feasibility and finalize procedures, and examine the potential efficacy of
4 CT arms relative to an active control. We will apply improved methodology by comparing the CT arms to a
stringent active control condition of cognitive stimulation with equivalent participant expectations and social in-
teraction. Measures will include innovative indices of instrumental activities of daily living (IADL), standard cog-
nitive assessments, as well as neuroimaging and blood-based biomarkers. Potential moderators of CT will also
be assessed. The phase I pilot data will inform statistical simulations to design a seamless phase II/III adaptive
RCT. We will simulate participant accrual and several treatment scenarios. For each scenario, we will deter-
mine statistical power and sample size required for trial success. The results of these statistical simulations will
be applied to optimize design and power for the phase II/III adaptive RCT. The resulting RCT will be innova-
tive, in our opinion, in the application of adaptive trial methodology to efficiently identify the most efficacious
combinations of CT exercises to delay dementia onset. We will plan the first trial to compare combinations of
CT exercises on conversion to dementia among persons with MCI. We will document CT-related changes in
the brain with neuroimaging and explore blood-based biomarkers as potential intermediary outcomes of CT.
The long term goal is to apply the best CT techniques to delay dementia onset, thereby promoting public
health. The contributions will be significant, advancing our understanding of how CT may be implemented to
curb dementia prevalence.
项目摘要
我们对ACTIVE研究的分析表明,一种类型的有针对性的认知训练(CT)可以降低
痴呆症在10年内下降了48%。虽然这些结果是令人鼓舞的,但证据是不确定的,
推荐CT预防痴呆。现在存在许多有效的CT技术,但具有不同的认知功能。
方面的影响.鉴于认知缺陷在痴呆症风险人群中各不相同,CT技术和
尼克可能是最有效的。新出现的证据表明,结合CT技术可以实现-
增强或减弱认知增益。然而,没有研究被设计来确定最有效的
CT组合。此外,没有研究被设计来检查CT对
痴呆诊断我们将聘请国际专家在CT,轻度认知障碍(MCI)/痴呆症,
招募和保留,神经心理学评估,神经影像学,生物标志物和适应性试验,
签署计划和试点测试适应性随机临床试验(RCT)。RCT将确定最有效的-
CT运动的有效组合,以减轻老年人的功能下降和延迟痴呆症,
由于MCI的风险。我们将首先制定一个有效的社区参与招聘计划,
通常在临床研究中代表性不足,并招募了一个代表美国老年人群体的样本,
在性别、民族、种族和教育方面的歧视。在第一阶段,将进行一项试验性试验,以改进重新设计的
审查和保留计划,建立可行性和最后确定程序,并审查
4个CT臂相对于主动控制。我们将通过将CT臂与
认知刺激严格主动控制条件下的参与者期望和社会影响
相互作用措施将包括工具性日常生活活动(IADL)的创新指数,标准齿轮,
神经影像学和血液生物标志物。CT的潜在主持人也将
被评估。第一阶段试验数据将为统计模拟提供信息,以设计无缝的第二/第三阶段自适应
RCT。我们将模拟受试者招募和几种治疗方案。对于每一种情况,我们都会阻止-
挖掘试验成功所需的统计功效和样本量。这些统计模拟的结果将
用于优化II/III期自适应RCT的设计和功耗。结果RCT将是创新的-
我们认为,在应用适应性试验方法,以有效地确定最有效的
CT运动的组合来延迟痴呆症的发作。我们将计划进行第一次试验,
MCI患者向痴呆症转化的CT练习。我们将记录与CT相关的变更,
脑神经影像学和探索血液为基础的生物标志物作为潜在的中间结果的CT。
长期目标是应用最好的CT技术来延迟痴呆症的发作,从而促进公众
健康这些贡献将是巨大的,将促进我们对如何实施CT的理解,
控制痴呆症的流行。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jerri Edwards其他文献
Jerri Edwards的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jerri Edwards', 18)}}的其他基金
Cognitive training to reduce incidence of cognitive impairment in older adults
认知训练可降低老年人认知障碍的发生率
- 批准号:
10334504 - 财政年份:2021
- 资助金额:
$ 97.9万 - 项目类别:
Supplement to Cognitive training to reduce incidence of cognitive impairment in older adults
认知训练的补充可降低老年人认知障碍的发生率
- 批准号:
10517797 - 财政年份:2021
- 资助金额:
$ 97.9万 - 项目类别:
Cognitive training to reduce incidence of cognitive impairment in older adults
认知训练可降低老年人认知障碍的发生率
- 批准号:
10589134 - 财政年份:2021
- 资助金额:
$ 97.9万 - 项目类别:
Cognitive Speed of Processing Training Among Persons with Parkinson?s Disease
帕金森病患者处理训练的认知速度
- 批准号:
7915655 - 财政年份:2009
- 资助金额:
$ 97.9万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 97.9万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 97.9万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 97.9万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 97.9万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 97.9万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 97.9万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 97.9万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 97.9万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 97.9万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 97.9万 - 项目类别:














{{item.name}}会员




